4//SEC Filing
Meek David D. 4
Accession 0001209191-23-052879
CIK 0001805890other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 5:00 PM ET
Size
5.3 KB
Accession
0001209191-23-052879
Insider Transaction Report
Form 4
Meek David D.
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-10-16+34,000→ 34,000 totalExercise: $4.16Exp: 2033-10-16→ Common Stock (34,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in 36 substantially equal monthly installments starting on November 16, 2023.
Documents
Issuer
Fusion Pharmaceuticals Inc.
CIK 0001805890
Entity typeother
Related Parties
1- filerCIK 0001555337
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 5:00 PM ET
- Size
- 5.3 KB